论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
ZNF217:一种致癌转录因子和多种人类癌症的潜在治疗靶点
Authors Wang Y, Ma C , Yang X, Gao J, Sun Z
Received 18 July 2023
Accepted for publication 27 December 2023
Published 18 January 2024 Volume 2024:16 Pages 49—62
DOI https://doi.org/10.2147/CMAR.S431135
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Professor Lu-Zhe Sun
Abstract: Zinc finger protein 217 (ZNF217) is one of the well-researched members of the Krüppel-like factor transcription factor family. ZNF217 possesses a characteristic structure of zinc finger motifs and plays a crucial role in regulating the biological activities of cells. Recent findings have revealed that ZNF217 is strongly associated with multiple aspects of cancer progression, impacting patient prognosis. Notably, ZNF217 is subject to regulation by non-coding RNAs, suggesting the potential for targeted manipulation of such RNAs as a robust therapeutic avenue for managing cancer in the future. The main purpose of this article is to provide a detailed examination of the role of ZNF217 in human malignant tumors and the regulation of its expression, and to offer new perspectives for cancer treatment.
Keywords: oncogene, regulation, non-coding RNA, targeted therapy